NDC product
Cafergot
NDC 73352-917 · Trifluent Pharma, LLC
Key facts
| Product NDC | 73352-917 |
|---|---|
| Proprietary name | Cafergot |
| Nonproprietary name | ergotamine tartrate and caffeine |
| Substances | ERGOTAMINE TARTRATE, CAFFEINE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Trifluent Pharma, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA040590 |
| Pharmacologic classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Ergotamine Derivative [EPC], Ergotamines [CS], Methylxanthine [EPC], Xanthines [CS] |
| Marketing start | Mar 23, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: